July 1, 2012

Bristol-Myers to buy diabetes drug maker for $5B

(AP) — Drug maker Bristol-Myers Squibb Co. says it agreed to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash.

Bristol-Myers says it will pay $31 per share for Amylin in a cash tender offer.

Including Amylin's debt and a contractual payment obligation to Eli Lilly & Co., the deal is worth about $7 billion.

The deal was announced Friday. After it is complete, Bristol-Myers will enter into an alliance with drug maker AstraZeneca to develop and commercialize Amylin's portfolio of drugs. AstraZeneca will pay Bristol-Myers $3.4 billion in , and both companies will share profits and losses.

Bristol-Myers says the deal will hurt earnings in 2012 and 2013 by 3 cents per .

Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Citation: Bristol-Myers to buy diabetes drug maker for $5B (2012, July 1) retrieved 19 April 2024 from https://medicalxpress.com/news/2012-07-bristol-myers-diabetes-drug-maker-5b.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Bristol-Myers Squibb to buy Inhibitex for $2.5 billion
 shares

Feedback to editors
Researchers discover glial hyper-drive for triggering epileptic seizures

24 minutes ago
Deeper dive into the gut microbiome shows changes linked to body weight

26 minutes ago
A new therapeutic target for traumatic brain injury

41 minutes ago
Dozens of COVID virus mutations arose in man with longest known case, research finds

47 minutes ago
Researchers explore causal machine learning, a new advancement for AI in health care

48 minutes ago
Analyzing the progression in retinal thickness could predict cognitive progression in Parkinson's patients

49 minutes ago
Researchers discover dynamic DNA structures that regulate the formation of memory

1 hour ago
Potential modifier gene identified as cause of ciliary pathology in retinitis pigmentosa patient

1 hour ago
Retrospective genomic characterization of the 2020 Ebola outbreak

2 hours ago
Using AI to trace the origins of metastatic cancer cells

4 hours ago
Load comments (0)